By Ransdell Pierson and Natalie Grover
(Reuters) – Valeant Pharmaceuticals International Inc (N:) on Monday said a group of company executives will immediately take over for its chief executive officer until he returns from medical leave, sending shares tumbling 10 percent.
The Canadian company said CEO Michael…
Valeant to be led by group of executives while CEO fights pneumonia
No comments:
Post a Comment